| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |